Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Cellular Physiology|June 29, 2012
Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasisAntonia Bellizzi, Sinto Sebastian, Pasquale Ceglia, et al.Journal of Cellular Physiology|January 19, 2010
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancerDaniele Santini, Bruno Vincenzi, Maria Elisabetta Fratto, et al.Journal of Cellular and Molecular Medicine|November 29, 2013
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patientsFrancesco Pantano, Pierpaolo Berti, Francesco Maria Guida, et al.Journal of Cellular Physiology|April 20, 2011
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patientsBruno Vincenzi, Daniele Santini, Giuseppe Perrone, et al.Current Cancer Drug Targets|June 29, 2010
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)Daniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.Oncotarget|March 20, 2016
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statusGiuseppe Bronte, Tindara Franchina, Massimiliano Alù, et al.Pulmonary Therapy|June 5, 2021
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung CancerVittorio Gebbia, Aurelia Guarini, Dario Piazza, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 17, 2024
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus/human herpesvirus-8 infections for early recognition and effective treatment of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome in solid organ transplant recipientsAlessandra Mularoni, Andrea Cona, Matteo Bulati, et al.The Lancet. Oncology|February 28, 2018
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trialSabino De Placido, Ciro Gallo, Michelino De Laurentiis, et al.Pageof 7